Usage Examples
- Log it as an adverse event now; causality gets adjudicated at the data review meeting, not by the coordinator.
- That adverse event is serious and unexpected, so we are on a 15-day clock from the day we received it.
- All adverse events were coded to MedDRA preferred terms before the safety tables were run.
What is Adverse Event (AE)?
Adverse Event (AE) is any untoward medical occurrence in a patient or clinical trial subject administered a pharmaceutical product, recorded whether or not it is considered drug related; causality is assessed separately, not presumed.
Adverse Event is the regulatory unit of observation for drug harm. A sponsor cannot know in advance which occurrences a product causes, so the regulations require the observation to be captured before the judgment is made. Recording first and adjudicating later is what prevents a real signal from being discarded because someone decided early that the drug was not responsible.
An Adverse Event covers any unfavorable and unintended sign, symptom, abnormal laboratory finding or disease temporally associated with product use, in trials and in marketed practice. It stops at causality: an adverse event that a reasonable possibility links to the drug becomes a suspected adverse reaction, and only that subset, when serious and unexpected, triggers expedited reporting. After approval the scope also pulls in overdose, abuse, withdrawal and failure of expected pharmacological action.
An Adverse Event moves through four determinations in practice: seriousness against fixed outcome criteria, severity as a clinical intensity grade, expectedness against the Investigator's Brochure or approved labeling, and causality. Seriousness plus unexpectedness plus a reasonable causal possibility is what starts the 7 or 15 calendar-day clock. In blinded studies ICH E2A recommends breaking the blind only for the specific patient whose reaction qualifies for expedited reporting.
Not to be confused with
- Adverse Drug Reaction (ADR)
- an ADR requires at least a reasonable possibility of a causal relationship to the product; an adverse event requires none. Inside an IND, FDA's term for that causal subset is "suspected adverse reaction".
- Serious Adverse Event (SAE)
- seriousness is an outcome test (death, life-threatening, inpatient hospitalization, persistent disability, congenital anomaly), not a verdict on cause. An SAE is a subset of adverse events and can be entirely unrelated to the drug.
- Severe adverse event
- severity grades intensity, seriousness grades consequence. ICH E2A is explicit that seriousness, not severity, guides reporting obligations, so a severe headache is usually not reportable and a mild event that forces hospitalization is.
- Side effect
- ICH E2A recommends this term no longer be used and warns specifically against treating it as synonymous with adverse event or adverse reaction. It is not a defined regulatory category and carries no reporting consequence.
The obligations differ before and after approval, and these are the anchors that set the clocks.
What you must do
- 1Capture the occurrence as an adverse event without waiting for a causal link, because the definition does not require a causal relationship with treatmentICH E2A section II.A.1
- 2Record every untoward medical occurrence associated with drug use in humans, whether or not considered drug related, and separately assess whether a reasonable possibility exists that the drug caused it21 CFR 312.32(a)
- 3Report every serious adverse event to the sponsor immediately, whether or not you consider it drug related21 CFR 312.64(b)
- 4Notify FDA and participating investigators of a serious and unexpected suspected adverse reaction in no case later than 15 calendar days, and in no case later than 7 calendar days after initial receipt when it is fatal or life-threatening21 CFR 312.32(c)
- 5After approval, submit each serious and unexpected adverse drug experience, foreign or domestic, no later than 15 calendar days from initial receipt of the information21 CFR 314.80(c)(1)(i)
Common mistakes
Filtering adverse events by presumed causality at the site
coordinators drop occurrences they judge unrelated before the event reaches the database. 21 CFR 312.64(b) requires the investigator to report every serious adverse event to the sponsor whether or not it is considered drug related, and pre-filtering destroys the denominator any later signal detection depends on.
Treating the severity grade as the reporting trigger
a "severe" grade is an intensity judgment, not a seriousness determination. Teams escalate severe-but-nonserious events that carry no obligation and miss the mild event that caused an overnight admission, which is the one on a 15-day clock.
Starting the clock from the wrong date
the fatal or life-threatening clock runs from the sponsor's initial receipt of the information, not from case completion, medical review or narrative sign-off. A case that sits in triage for four days leaves three days to assess, compile and submit the IND safety report.
When This Matters
- Log it as an adverse event now; causality gets adjudicated at the data review meeting, not by the coordinator.
- That adverse event is serious and unexpected, so we are on a 15-day clock from the day we received it.
- All adverse events were coded to MedDRA preferred terms before the safety tables were run.
Frequently Asked Questions
An adverse event is recorded regardless of cause, while an adverse reaction requires a reasonable possibility that the drug caused it. FDA calls that causal subset a suspected adverse reaction under 21 CFR 312.32(a). Every adverse reaction is an adverse event; most adverse events never become reactions.
